Thrivent Financial for Lutherans Sells 75,008 Shares of Waters Corporation $WAT

Thrivent Financial for Lutherans lessened its position in Waters Corporation (NYSE:WAT) by 21.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 277,051 shares of the medical instruments supplier’s stock after selling 75,008 shares during the period. Thrivent Financial for Lutherans owned about 0.47% of Waters worth $96,702,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd bought a new position in Waters during the first quarter worth about $41,000. IFP Advisors Inc lifted its position in shares of Waters by 65.4% in the second quarter. IFP Advisors Inc now owns 134 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 53 shares during the last quarter. CYBER HORNET ETFs LLC bought a new position in shares of Waters during the 2nd quarter worth approximately $53,000. MUFG Securities EMEA plc acquired a new position in shares of Waters during the 2nd quarter worth approximately $61,000. Finally, Creative Financial Designs Inc. ADV raised its stake in Waters by 533.3% in the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock valued at $66,000 after acquiring an additional 160 shares during the period. 94.01% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on WAT. JPMorgan Chase & Co. lifted their price objective on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Wolfe Research raised shares of Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 target price for the company in a report on Wednesday. TD Cowen upped their price target on shares of Waters from $345.00 to $390.00 and gave the company a “hold” rating in a research note on Wednesday, November 5th. Redburn Partners set a $390.00 price objective on shares of Waters in a research report on Wednesday, October 8th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $390.31.

Waters Price Performance

Shares of Waters stock opened at $385.35 on Friday. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. The stock has a market capitalization of $22.94 billion, a price-to-earnings ratio of 35.42, a price-to-earnings-growth ratio of 3.50 and a beta of 1.16. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The company has a 50-day simple moving average of $368.33 and a two-hundred day simple moving average of $333.58.

Waters (NYSE:WAT) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The company had revenue of $608.55 million for the quarter. Waters had a net margin of 20.89% and a return on equity of 36.59%. Analysts forecast that Waters Corporation will post 12.86 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.